Carbidopa and Levodopa
Active substance: CARBIDOPA HYDRATE, LEVODOPA
TABLET, EXTENDED RELEASE · CARBIDOPA HYDRATE 50 mg/1, LEVODOPA 200 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals NY LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CARBIDOPA HYDRATE · 50 mg/1
- LEVODOPA · 200 mg/1
Registration
- Registration number
- 60219-2034
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 60219-2034 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 60219-2034 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 60219-2034 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 60219-2034 · Verified 2026-10-09 · open in source